Headline News about Coherus BioVia Benzinga
Junshi Biosciences, Coherus Receive FDA Breakthrough Therapy Status For Toripalimab In Head & Neck Cancer
August 12, 2021
Via Benzinga
Exposures
Product Safety
Coherus BioSciences, inc (CHRS) Q2 2021 Earnings Call Transcript
August 06, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|